Marcel Levi

60.1k total citations · 19 hit papers
526 papers, 38.8k citations indexed

About

Marcel Levi is a scholar working on Hematology, Internal Medicine and Epidemiology. According to data from OpenAlex, Marcel Levi has authored 526 papers receiving a total of 38.8k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Hematology, 153 papers in Internal Medicine and 145 papers in Epidemiology. Recurrent topics in Marcel Levi's work include Blood Coagulation and Thrombosis Mechanisms (184 papers), Venous Thromboembolism Diagnosis and Management (153 papers) and Sepsis Diagnosis and Treatment (106 papers). Marcel Levi is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (184 papers), Venous Thromboembolism Diagnosis and Management (153 papers) and Sepsis Diagnosis and Treatment (106 papers). Marcel Levi collaborates with scholars based in Netherlands, United States and United Kingdom. Marcel Levi's co-authors include Tom van der Poll, Hugo Ten Cate, Toshiaki Iba, Jerrold H. Levy, Jecko Thachil, Evert de Jonge, Harry R. Büller, Joost C.M. Meijers, Marcus J. Schultz and Cheng‐Hock Toh and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Marcel Levi

518 papers receiving 37.6k citations

Hit Papers

Towards Definition, Clinical and Laboratory Criteria, and... 1999 2026 2008 2017 2001 1999 2020 2020 2011 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation
    2001 1.6k citations Marcel Levi et al. profile →
  2. Disseminated Intravascular Coagulation
    1999 1.4k citations Marcel Levi, Hugo Ten Cate profile →
  3. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
    2020 1.3k citations Jecko Thachil, Marcel Levi et al. Journal of Thrombosis and Haemostasis profile →
  4. Coagulation abnormalities and thrombosis in patients with COVID-19
    2020 1.0k citations Marcel Levi, Jecko Thachil et al. profile →
  5. Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
    2011 997 citations Elise S. Eerenberg, Pieter W. Kamphuisen et al. Circulation profile →
  6. New Fundamentals in Hemostasis
    2013 777 citations Marcel Levi et al. profile →
  7. Inflammation and coagulation
    2010 716 citations Marcel Levi, Tom van der Poll Critical Care Medicine profile →
  8. Bidirectional Relation Between Inflammation and Coagulation
    2004 687 citations Marcel Levi, Tom van der Poll et al. Circulation profile →
  9. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
    2021 656 citations Marcel Levi et al. profile →
  10. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
    2021 619 citations Marcel Levi et al. profile →
  11. Coagulation and sepsis
    2016 557 citations Marcel Levi, Tom van der Poll profile →
  12. Acute Coagulopathy of Trauma: Hypoperfusion Induces Systemic Anticoagulation and Hyperfibrinolysis
    2008 538 citations Marcus J. Schultz, Marcel Levi et al. profile →
  13. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19
    2020 440 citations Jerrold H. Levy, Jean M. Connors et al. Journal of Thrombosis and Haemostasis profile →
  14. Safety of Recombinant Activated Factor VII in Randomized Clinical Trials
    2010 432 citations Marcel Levi, Jerrold H. Levy et al. profile →
  15. Coagulopathy in COVID‐19
    2020 384 citations Toshiaki Iba, Jerrold H. Levy et al. Journal of Thrombosis and Haemostasis profile →
  16. Disseminated intravascular coagulation
    2016 374 citations Marcel Levi et al. profile →
  17. Coagulopathy of Coronavirus Disease 2019
    2020 352 citations Toshiaki Iba, Jerrold H. Levy et al. Critical Care Medicine profile →
  18. Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
    2019 330 citations Toshiaki Iba, Jerrold H. Levy et al. Journal of Thrombosis and Haemostasis profile →
  19. The unique characteristics of COVID-19 coagulopathy
    2020 329 citations Toshiaki Iba, Jerrold H. Levy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcel Levi Netherlands 94 9.8k 9.3k 7.7k 6.6k 6.6k 526 38.8k
Jerrold H. Levy United States 76 3.4k 0.3× 3.0k 0.3× 4.6k 0.6× 6.8k 1.0× 6.2k 0.9× 472 23.6k
Tom van der Poll Netherlands 116 5.6k 0.6× 30.8k 3.3× 2.2k 0.3× 4.1k 0.6× 8.3k 1.3× 876 71.6k
Hugo Ten Cate Netherlands 76 7.7k 0.8× 3.5k 0.4× 5.5k 0.7× 5.6k 0.9× 3.3k 0.5× 568 21.5k
Harry R. Büller Netherlands 92 8.2k 0.8× 3.5k 0.4× 24.6k 3.2× 18.6k 2.8× 8.6k 1.3× 450 35.7k
Ernest E. Moore United States 113 1.9k 0.2× 6.8k 0.7× 1.9k 0.2× 2.4k 0.4× 24.4k 3.7× 1.1k 49.9k
Jeffrey I. Weitz Canada 98 9.2k 0.9× 3.6k 0.4× 21.1k 2.7× 23.9k 3.6× 9.0k 1.4× 528 41.9k
Steven M. Opal United States 68 1.8k 0.2× 24.8k 2.7× 709 0.1× 2.7k 0.4× 6.4k 1.0× 275 44.6k
Guy A. Zimmerman United States 98 5.5k 0.6× 3.7k 0.4× 1.1k 0.1× 2.9k 0.4× 3.9k 0.6× 262 32.6k
Dean Fergusson Canada 83 2.5k 0.3× 3.2k 0.3× 1.3k 0.2× 2.7k 0.4× 5.4k 0.8× 673 26.8k
Bernd Jilma Austria 64 4.4k 0.5× 2.5k 0.3× 2.1k 0.3× 4.8k 0.7× 2.4k 0.4× 562 16.7k

Countries citing papers authored by Marcel Levi

Since Specialization
Citations

This map shows the geographic impact of Marcel Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Levi more than expected).

Fields of papers citing papers by Marcel Levi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Levi. The network helps show where Marcel Levi may publish in the future.

Co-authorship network of co-authors of Marcel Levi

This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Levi. A scholar is included among the top collaborators of Marcel Levi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Levi. Marcel Levi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iba, Toshiaki, Jerrold H. Levy, Cheryl L. Maier, Jean M. Connors, & Marcel Levi. (2024). Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?. Journal of Thrombosis and Haemostasis. 22(6). 1541–1549. 9 indexed citations
2.
Levi, Marcel & Toshiaki Iba. (2024). Organ Dysfunction in Sepsis-associated Intravascular Coagulation. Juntendo Medical Journal. 70(1). 26–28. 2 indexed citations
3.
Iba, Toshiaki, Jerrold H. Levy, Jecko Thachil, et al.. (2023). Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis. 21(3). 691–699. 20 indexed citations
4.
Krzywicka, Katarzyna, Diana Aguiar de Sousa, Mayte Sánchez van Kammen, et al.. (2021). Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS‐CoV‐2 vaccination. European Journal of Neurology. 29(1). 339–344. 40 indexed citations
5.
Hofstra, Jorrit J., Xanthe Brands, Marcel Levi, et al.. (2016). Nebulized Recombinant Human Tissue Factor Pathway Inhibitor Attenuates Coagulation and Exerts Modest Anti-inflammatory Effects in Rat Models of Lung Injury. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 30(2). 91–99. 14 indexed citations
6.
Cornet, Alexander D., Jorrit J. Hofstra, Alexander P. J. Vlaar, et al.. (2011). Nebulized Anticoagulants Limit Coagulopathy But Not Inflammation in Pseudomonas aeruginosa-Induced Pneumonia in Rats. Shock. 36(4). 417–423. 10 indexed citations
7.
Eerenberg, Elise S., Pieter W. Kamphuisen, Meertien K. Sijpkens, et al.. (2011). Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate. Circulation. 124(14). 1573–1579. 997 indexed citations breakdown →
8.
Lichtman, Marshall A., et al.. (2011). Williams manual of hematology. 16 indexed citations
9.
Vlaar, Alexander P. J., Jorrit J. Hofstra, Marcel Levi, et al.. (2010). Supernatant of Aged Erythrocytes Causes Lung Inflammation and Coagulopathy in a “Two-Hit”In Vivo  Syngeneic Transfusion Model. Anesthesiology. 113(1). 92–103. 100 indexed citations
10.
Levi, Marcel & Tom van der Poll. (2010). Inflammation and coagulation. Critical Care Medicine. 38(2 Suppl). S26–S34. 716 indexed citations breakdown →
11.
Vlaar, Alexander P. J., Jorrit J. Hofstra, Wim Kulik, et al.. (2010). Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood. 116(8). 1360–1368. 83 indexed citations
12.
Hofstra, Jorrit J., Alexander P. J. Vlaar, Alexander D. Cornet, et al.. (2010). Nebulized Anticoagulants Limit Pulmonary Coagulopathy, But Not Inflammation, in a Model of Experimental Lung Injury. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(2). 105–111. 34 indexed citations
13.
Vink, Roel, et al.. (2009). Perioperatieve onderbreking van antistollingsmiddelen: Praktische aanbevelingen. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 153(33). 1622–1628. 1 indexed citations
14.
Levi, Marcel, et al.. (2009). Perioperatieve onderbreking van antistollingsmiddelen. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 153. 1 indexed citations
15.
Nieuwdorp, Max, Marijn C. Meuwese, Hans L. Mooij, et al.. (2008). Tumor necrosis factor-α inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis. 202(1). 296–303. 140 indexed citations
16.
Choi, Goda, et al.. (2006). The relationship between inflammation and the coagulation system. Swiss Medical Weekly. 136(910). 139–144. 55 indexed citations
17.
Poll, Tom van der, Marcel Levi, Jerry A. Nick, & Edward Abraham. (2005). Activated Protein C Inhibits Local Coagulation after Intrapulmonary Delivery of Endotoxin in Humans. American Journal of Respiratory and Critical Care Medicine. 171(10). 1125–1128. 78 indexed citations
18.
Jonge, Evert de, Marieke J. Schuurmans, Roos C. van der Mast, & Marcel Levi. (2005). Clinical subtypes of delirium and their relevance for daily clinical practice: a systematic review. International Journal of Geriatric Psychiatry. 20(7). 609–615. 62 indexed citations
19.
Levi, Marcel, et al.. (2000). [Physical diagnosis--percussion and palpation of liver].. PubMed. 144(18). 835–8. 2 indexed citations
20.
Levi, Marcel, Hugo Ten Cate, KA Bauer, et al.. (1994). Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.. Journal of Clinical Investigation. 93(1). 114–120. 317 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerrold H. Levy Breakdown of academic impact, for papers by Tom van der Poll Breakdown of academic impact, for papers by Hugo Ten Cate Breakdown of academic impact, for papers by Harry R. Büller Breakdown of academic impact, for papers by Ernest E. Moore Breakdown of academic impact, for papers by Jeffrey I. Weitz Breakdown of academic impact, for papers by Steven M. Opal Breakdown of academic impact, for papers by Guy A. Zimmerman Breakdown of academic impact, for papers by Dean Fergusson Breakdown of academic impact, for papers by Bernd Jilma
Rankless by CCL
2026